Natera, Inc. (NTRA)
325.52
-2.15
(-0.66%)
USD |
NASDAQ |
Sep 04, 14:09
Natera Cash from Investing (Quarterly) : -63.43M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -63.43M |
| March 31, 2026 | -32.14M |
| December 31, 2025 | -71.59M |
| September 30, 2025 | -19.90M |
| June 30, 2025 | -23.90M |
| March 31, 2025 | -16.82M |
| December 31, 2024 | -11.12M |
| September 30, 2024 | 42.54M |
| June 30, 2024 | -32.05M |
| March 31, 2024 | 138.26M |
| December 31, 2023 | 24.66M |
| September 30, 2023 | 81.15M |
| June 30, 2023 | 47.03M |
| March 31, 2023 | 15.65M |
| December 31, 2022 | 21.92M |
| September 30, 2022 | 66.60M |
| June 30, 2022 | 34.79M |
| March 31, 2022 | 207.03M |
| December 31, 2021 | 79.50M |
| September 30, 2021 | -431.41M |
| June 30, 2021 | 59.97M |
| March 31, 2021 | 86.74M |
| December 31, 2020 | -99.17M |
| September 30, 2020 | -110.34M |
| June 30, 2020 | -165.45M |
| Date | Value |
|---|---|
| March 31, 2020 | 43.49M |
| December 31, 2019 | -195.24M |
| September 30, 2019 | 29.89M |
| June 30, 2019 | -113.91M |
| March 31, 2019 | 12.92M |
| December 31, 2018 | 21.69M |
| September 30, 2018 | -60.53M |
| June 30, 2018 | 8.626M |
| March 31, 2018 | 25.06M |
| December 31, 2017 | 27.52M |
| September 30, 2017 | -41.24M |
| June 30, 2017 | 9.786M |
| March 31, 2017 | 17.72M |
| December 31, 2016 | 16.94M |
| September 30, 2016 | 32.53M |
| June 30, 2016 | -5.699M |
| March 31, 2016 | 3.261M |
| December 31, 2015 | -177.87M |
| September 30, 2015 | -26.77M |
| June 30, 2015 | -2.288M |
| March 31, 2015 | -3.749M |
| December 31, 2014 | |
| September 30, 2014 | -0.246M |
| June 30, 2014 | -3.27M |
| March 31, 2014 | -2.601M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Guardant Health, Inc. | 101.47M |
| CareDx, Inc. | 280.59M |
| Myriad Genetics, Inc. | -3.20M |
| BioRestorative Therapies, Inc. | 0.9684M |
| Exagen, Inc. | -0.543M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 54.79M |
| Cash from Financing (Quarterly) | 12.21M |
| Free Cash Flow | 51.20M |
| Free Cash Flow Per Share (Quarterly) | -0.0603 |
| Free Cash Flow to Equity (Quarterly) | -7.043M |
| Free Cash Flow to Firm (Quarterly) | -7.750M |
| Free Cash Flow Yield | 0.11% |